Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07239609 · ClinicalTrials.gov registry record · Phase 1
ACT for Individuals With MNCD and Their Care Partners
A Phase 1 study, sponsored by Texas Tech University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT07239609 is a Phase 1 study that is actively recruiting participants, run by Texas Tech University. The registered enrollment target is 100 participants.
The verdict
NCT07239609, a Phase 1 study, is actively recruiting participants, sponsored by Texas Tech University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
This project aims to implement and evaluate a dyadic intervention (i.e., acceptance commitment therapy) for persons with AD/ADRD and their care partners. We hypothesize the intervention will be feasible, acceptable, and show preliminary efficacy of the dyadic interveniotns.
Interventions
- BEHAVIORAL Acceptance Commitment Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07239609
The ClinicalTrials.gov registry entry for NCT07239609 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acceptance Commitment Therapy is the first listed.
NCT07239609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07239609 about?
NCT07239609 is a clinical study titled "ACT for Individuals With MNCD and Their Care Partners". This project aims to implement and evaluate a dyadic intervention (i.e., acceptance commitment therapy) for persons with AD/ADRD and their care partners. We hypothesize the intervention will be feasible, acceptable, and show preliminary efficacy of the dyadic interveniotns.
What is the current status of trial NCT07239609?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2026-04-01. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07239609?
The interventions under investigation include: Acceptance Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07239609?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.